Dry Age-Related Macular Degeneration – A New Approach In Optical Coherence Tomography Monitoring And Quantitative Assessment

1. Rattner, A. Nathans J. Macular Degeneration: Recent Advances and Therapeutic Opportunities. Nat Rev eurosci. 2006,7(11):860-72.10.1038/nrn2007Search in Google Scholar

2. Haddad S, Chen CA, Santangelo SL, Seddon JM. The Genetics of Age-Related Macular Degeneration: A Review of Progress to Date. Surv Ophthalmol. 2006;51(4):316-63.10.1016/j.survophthal.2006.05.001Search in Google Scholar

3. Age-Related Eye Disease Study Research Group. A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No 8. Arch Ophthalmol. 2001; 119(10):1417-36.10.1001/archopht.119.10.1417Search in Google Scholar

4. Klein R, Klein BE, Linton KL. Prevalence of Age-Related Maculopathy. The Beaver Dam Eye Study. Ophthalmology, 1992, 99(6), 933-43.10.1016/S0161-6420(92)31871-8Search in Google Scholar

5. Friedman DS, O’Colmain BJ, Muсoz B, Tomany SC, McCarty C, de Jong PTVM, et al. Eye Diseases Prevalence Research Group. Prevalence of Age-Related Macular Degeneration in the United States. Arch Ophthalmol. 2004; 122(4):564-72.10.1001/archopht.1941.00870100042005Search in Google Scholar

6. Augood CA, Vingerling JR, de Jong PTVM, Chakravarthy U, Seland J, Soubrane G, et al. Prevalence of Age-Related Maculopathy in Older Europeans: The European Eye Study (EUREYE). Arch Ophthalmol. 2006;124(4):529-35.10.1001/archopht.124.4.52916606879Search in Google Scholar

7. Chen Y, Bedell M, Zhang K. Age-Related Macular Degeneration: Genetic and Environmental Factors of Disease. Mol Interv. 2010;10(5):271-81.10.1124/mi.10.5.4300221821045241Search in Google Scholar

8. Campochiaro PA. Ocular Neovascularisation and Excessive Vascular Permeability. Expert Opin Biol Ther. 2004;4(9):1395-402.10.1517/14712598.4.9.139515335307Search in Google Scholar

9. Fine SL, Berger JW, Maguire MG, Ho AC. Age-Related Macular Degeneration. N Engl J Med. 2000;342:483-92.10.1056/NEJM20000217342070710675430Search in Google Scholar

10. Kijlstra A, La Heij E, Hendrikse F. Immunological Factors in the Pathogenesis and Treatment of Age-Related Macular Degeneration. Ocul Immunol Inflamm. 2005;13(1):3-11.10.1080/0927394059090918515804763Search in Google Scholar

11. Klein R, Peto T, Bird A, Vannewkirk MR. The Epidemiology of Age-Related Macular Degeneration. Am J Ophthalmol. 2004; 137(3):486-95.10.1016/j.ajo.2003.11.069Search in Google Scholar

12. McConnell V, Silvestri G. Age-Related Macular Degeneration. Ulster Med J. 2005;74(2):82-92.Search in Google Scholar

13. Bok, D. Evidence for an Inflammatory Process in Age-Related Macular Degeneration Gains New Support. Proc Natl Acad Sci U S A. 2005; 102(20):7053-4.10.1073/pnas.0502819102Search in Google Scholar

14. Kuehn BM. Gene Discovery Provides Clues to Cause of Age-Related Macular Degeneration. JAMA. 2005;293(15):1841-5.10.1001/jama.293.15.1841Search in Google Scholar

15. Loduca AL, Zhang C, Zelkha R, Shahidi M. Thickness Mapping of Retinal Layers by Spectral Domain Optical Coherence Tomography. Am J Ophthalmol. 2010;150(6);849-55.10.1016/j.ajo.2010.06.034Search in Google Scholar

16. Huang J, Liu X, Wu Z, Xiao H, Dustin L, Sadda S. Macular Thickness Measurements in Normal Eyes with Time Domain and Fourier Domain Optical Coherence Tomography. Retina. 2009;29(7):980-7.10.1097/IAE.0b013e3181a2c1a7Search in Google Scholar

17. Early Treatment Diabetic Retinopathy Study Design and Baseline Patient Characteristics. ETDRS Report Number 7. Ophthalmology. 1991;98(5 Suppl):741-56.10.1016/S0161-6420(13)38009-9Search in Google Scholar

18. Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, et al. Clinical Risk Factors for Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. BMC Ophthalmol. 2010;10:31.10.1186/1471-2415-10-31300961921144031Search in Google Scholar

19. Bressler SB, Mucoz B, Solomon SD, West SK, Salisbury Eye Evaluation (SEE) Study Team. Racial Differences in the Prevalence of Age-Related Macular Degeneration: The Salisbury Eye Evaluation (SEE) Project. Arch. Ophthalmol. 2008;126(2):241-5.Search in Google Scholar

20. Yehoshua Z, Wang F, Rosenfeld PJ, Penha FM, Feuer WJ, Gregori G. Natural History of Drusen Morphology in Age-Related Macular Degeneration Using Spectral Domain Optical Coherence Tomography. Ophthalmology. 2011;118(12):2434-41.10.1016/j.ophtha.2011.05.008318942621724264Search in Google Scholar

21. Gregori G, Wang F, Rosenfeld PJ, Yehoshua Z, Gregori NZ, Lujan BJ, et al. Spectral Domain Optical Coherence Tomography Imaging of Drusen in Nonexudative Age-Related Macular Degeneration. Ophthalmology. 2011; 118(7):1373-9.10.1016/j.ophtha.2010.11.013312949321388687Search in Google Scholar